Castellan Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3,700
| Closed | -$215K | – | 59 |
|
|
2023
Q3 | $215K | Sell |
3,700
-300
| -8% | -$17.4K | 0.15% | 58 |
|
|
2023
Q2 | $256K | Sell |
4,000
-26,725
| -87% | -$1.71M | 0.16% | 59 |
|
|
2023
Q1 | $2.13M | Sell |
30,725
-165
| -0.5% | -$11.4K | 1.45% | 42 |
|
|
2022
Q4 | $2.22M | Buy |
30,890
+16
| +0.1% | +$1.15K | 1.55% | 41 |
|
|
2022
Q3 | $2.2M | Buy |
30,874
+1,430
| +5% | +$102K | 1.71% | 27 |
|
|
2022
Q2 | $2.27M | Sell |
29,444
-1,345
| -4% | -$104K | 1.8% | 24 |
|
|
2022
Q1 | $2.25M | Buy |
30,789
+3,389
| +12% | +$248K | 1.56% | 31 |
|
|
2021
Q4 | $1.71M | Buy |
27,400
+3,350
| +14% | +$209K | 1.18% | 39 |
|
|
2021
Q3 | $1.42M | Sell |
24,050
-3,150
| -12% | -$186K | 0.73% | 59 |
|
|
2021
Q2 | $1.82M | Buy |
27,200
+2,400
| +10% | +$160K | 0.76% | 35 |
|
|
2021
Q1 | $1.57M | Buy |
24,800
+1,500
| +6% | +$94.7K | 0.84% | 37 |
|
|
2020
Q4 | $1.45M | Buy |
+23,300
| New | +$1.45M | 1.56% | 15 |
|